Decoding Histamine Receptor Modulation: The Role of Heterocyclic Compounds in Next-generation Antihistaminic Drugs.

Abstract

The field of heterocyclic chemistry is a vital area of medicinal chemistry, characterized by notable dynamism that helps develop many physiologically active drugs. The extensive presence of heterocycles in drugs, natural products, and biological intermediates underscores their importance in the development of contemporary drugs. Histamine is an important endogenous biogenic amine with various physiological and immunological roles, including the inflammatory response, gastric acid secretion, neurotransmission, and immune regulation. The physiological effects of histamine are mediated by its interaction with four types of histamine receptors (H1, H2, H3, and H4). Histaminergic agents are of significant therapeutic importance due to their involvement in various disorders through dysregulated activity. Antihistamines have found applications in the management of problems related to the stomach, allergies, and certain neurodegenerative disorders. These drugs act by blocking histamine receptors. The first- and second-generation H1 antihistamines continue to play an important role in treating motion sickness, urticaria, and allergic rhinitis, as well as other conditions associated with these conditions. However, modern analogues of these drugs are much safer and do not cause any sedation. This review discusses the diversity of heterocycles in antihistaminic drugs, their interactions with receptors, their medicinal value, and the medicinal chemistry approaches that have paved the way for the development of such antihistamines.